REG - MHP SE - Board Changes

MHP SEAnnouncement

17/05/2024 07:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240517:nRSQ8829Oa&default-theme=true

RNS Number : 8829O  MHP SE  17 May 2024

17 May 2024

MHP SE

("MHP" or "the Company")

Board Changes - Resignation of John Grant

MHP SE (LSE: MHPC), one of the leading international agro-industrial groups,
today announces changes to its Board of Directors. Mr John Grant after 18
years of highly professional and devoted Board membership, is resigning from
the MHP Board as an Independent NED, Senior Independent Director and as Chair
of the Audit & Risks Committee, effective as from 30 June 2024. The
resignation letter has been provided to the Chair of the Board on 14 May.

Dr John Rich, Executive Chair, commented:

"John Grant is resigning from the Board after a long tenor, and I would like
to thank him for his unmitigated support, wise advice, and uncompromising
commitment to MHP over the last 18 years. Together with John Grant we formed
the Board of MHP SE and took the Company to IPO in 2008 to start a journey
which proved to be one of the most successful agribusinesses globally in a
brief period of 25+ years. The collective management and board members steered
the Company through all the challenges we faced including war in 2014 and
again in 2022. John has been instrumental in the success of this Company and
has been a rock of support for the CEO/Founder, CFO, and me. I am grateful for
John's undivided attention and loyalty to our Company and the people that you
have worked with here one to one and your strong guidance and support will be
sorely missed".

For Investor Relations enquiries, please contact:

Anastasia Sobotiuk (Kyiv)
+38 050 339 29 99

 
+357 99 76 71 26
a.sobotyuk@mhp.com.ua

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAARMFTMTTBMBI